Recent Webinar

In Vivo Imaging: Targeted Fluorescent Contrast Agents for Image-Guided Cancer Surgery. Watch Now


Dutch Clinical Trial: NL37479.042.11M

Validation of Uptake of a VEGF-targeted Optical Fluorescent Imaging Tracer in Surgical Specimens of Breast Cancer and Application of Pre- and Intra-operative Human Molecular Fluorescence Imaging Techniques. A multicenter feasibility study. Learn More


Further Information

Email: Translational.Research@licor.com Phone: (1) 402-467-0904 For preclinical research: IRDye infrared dyes and imaging probes can be purchased on our Biotechnology website.

LI-COR Translational Research is working to facilitate the use of IRDye® 800CW for investigational use in clinical trials. IRDye® 800CW is manufactured under current good manufacturing practices (cGMP), has completed a toxicity study performed under GLP (good laboratory practice), and has drug master files (DMF) on record with U.S. and European regulatory authorities. With this work complete, the dye is ready for conjugation to targeted biomolecules for use in clinical trials for image-guided surgery.

LI-COR interviewed Dr. Go van Dam, a surgeon specializing in oncology at the Groningen University Medical Center in the Netherlands.

Real-time imaging of the subsequent lymph node excision from a mouse.